Abd El-Aty A.M., Goudah A., Abo El-Sooud K., El-Zorba H.Y., Shimoda M., Zhou H.H. 2004. Pharmacokinetic and bioavailability of florfenicol following intravenous, intramuscular and oral administration in rabbits. Vet. Res. Commun., 28: 515-524. https://doi.org/10.1023/b:verc.0000040241.06642.49
Adams P.E., Varma K.J., Powers T.E., Lamendola, J.F. 1987. Tissue concentrations and pharmacokinetics of florfenicol in male veal calves given repeated doses. Am. J. Vet. Res., 48: 1725-1732.
Arriagada F., Gunther G., Zabala I., Rubio-Retama J., Morales J. 2019. Development and Characterization of Florfenicol-Loaded BSA Nanoparticles as Controlled Release Carrier. AAPS Pharm. Sci. Tech., 20: 202. https://doi.org/10.1208/s12249-019-1419
[+]
Abd El-Aty A.M., Goudah A., Abo El-Sooud K., El-Zorba H.Y., Shimoda M., Zhou H.H. 2004. Pharmacokinetic and bioavailability of florfenicol following intravenous, intramuscular and oral administration in rabbits. Vet. Res. Commun., 28: 515-524. https://doi.org/10.1023/b:verc.0000040241.06642.49
Adams P.E., Varma K.J., Powers T.E., Lamendola, J.F. 1987. Tissue concentrations and pharmacokinetics of florfenicol in male veal calves given repeated doses. Am. J. Vet. Res., 48: 1725-1732.
Arriagada F., Gunther G., Zabala I., Rubio-Retama J., Morales J. 2019. Development and Characterization of Florfenicol-Loaded BSA Nanoparticles as Controlled Release Carrier. AAPS Pharm. Sci. Tech., 20: 202. https://doi.org/10.1208/s12249-019-1419
Bretzlaff K.N., Neff-Davis C.A., Ott R.S., Koritz G.D., Gustafsson B.K., Davis L.E. 1987. Florfenicol in non-lactating dairy cows: pharmacokinetics, binding to plasma proteins, and effects on phagocytosis by blood neutrophils. J. Vet. Pharmacol. Ther., 10: 233-240. https://doi.org/10.1111/j.1365-2885.1987.tb00534.x
Brewer N.R. 2006. Biology of the rabbit. J. Am. Assoc. Lab. Anim. Sci., 45: 8-24.
De Craene B.A., Deprez P., D´Haese E., Nelis H.J., Van den Bossche W., De Leenheer P. 1997. Pharmacokinetics of Florfenicol in Cerebrospinal Fluid and Plasma of Calves. Antimicrob. Agents Chemother., 41: 1991-1995. https://doi.org/10.1128/AAC.41.9.1991
Elimam M.M, Shantier S.W., Gadkariem E.A., Mohamed M.A. 2016. Development of spectrophotometric methods for the analysis of florfenicol in bulk and dosage forms. Int. J. Pharmacy Pharm. Sci., 8: 347-349.
Espinosa J., Ferreras M.C., Benavides J., Cuesta N., Pérez C., García M.J., García J.F., Pérez V. 2020. Causes of Mortality and Disease in Rabbits and Hares: A Retrospective Study. Animals (Basel), 10: 158. https://doi.org/10.3390/ani10010158
Gutierrez L., Lechuga T., Marcos X., García-Guzmán P., Gutierrez C., Sumano H. 2020. Comparative bioavailability of enrofloxacin in dogs when concealed in noncommercial morsels, either as a tablet or as enrofloxacin–alginate dried beads. J. Vet. Pharmacol. Ther., 44: 522-532. https://doi.org/10.1111/jvp.12925
Hariyadi D.M., Islam N. 2020. Current status of alginate in drug delivery. Adv. Pharmacol. Pharm. Sci., 2020: 1-16. https://doi.org/10.1155/2020/8886095
Jitendra C.S., Ashwini D. 2014. Kinetic modeling and comparison of in vitro dissolution profiles. World J. Pharm. Sci., 2: 302–309.
Karp F., Turino L.N., Estenoz D., Castro G.R., Islan G.A. 2019. Encapsulation of florfenicol by in situ crystallization into novel alginate-Eudragit RS® blended matrix for pH modulated release. J. Drug. Deliv. Sci. Technol., 54: 1-9. https://doi.org/10.1016/j.jddst.2019.101241
Koc K., Ozturk M., Kadioglu Y., Dogan E., Yanmaz L.E., Okumus Z. 2009. Pharmacokinetics of florfenicol after intravenous and intramuscular administration in New Zealand White rabbits. Res. Vet. Sci., 87: 102-105. https://doi.org/10.1016/j.rvsc.2008.10.010
Kowalski P., Konieczna L., Chmielewska A., Oledzka I., Plenis A., Bieniecki M., Lamparczyk H. 2005. Comparative evaluation between capillary electrophoresis and highperformance liquid chromatography for the analysis of florfenicol in plasma. J. Pharm. Biomed. Anal., 39: 983-989. https://doi.org/10.1016/j.jpba.2005.05.032
Lennox A. 2012. Respiratory disease and pasteurellosis. In: K.E. Quesenberry and J.W. Carpenter (Eds.) Ferrets, Rabbits and Rodents: Clinical Medicine and Surgery. 3rd Edition. Elsevier, USA, 205-216. https://doi.org/10.1016/B978-1-4160-6621-7.00016-6
Li X., Xie S., Pan Y., Qu W., Tao Y., Chen D., Huang L., Liu Z., Wang Y., Yuan Z. 2016. Preparation, characterization and pharmacokinetics of doxycycline hydrochloride and florfenicol polyvinylpyrroliddone microparticle entrapped with hydroxypropyl-β-cyclodextrin inclusion complexes suspension. Colloids Surf. B Biointerfaces, 141: 634-642. https://doi.org/10.1016/j.colsurfb.2016.02.027
Lupo B., Maestro A., Gutiérrez J.M., González C. 2015. Characterization of alginate beads with encapsulated cocoa extract toprepare functional food: Comparison of two gelation mechanisms. Food Hydrocoll., 49: 25-34. https://doi.org/10.1016/j.foodhyd.2015.02.023
Marciniec B., Stawny M., Hofman-Bieniek M., Naskrent M. 2008. Thermal and spectroscopic analysis of florfenicol irradiated in the solid-state. J. Therm. Anal. Calorim., 93: 733-737. https://doi.org/10.1007/s10973-008-9137-5
Martínez M.N., Toutain P.L., Turnidge J. 2013. The pharmacodynamics of antimicrobial agents. In: S. Giguère, J.F. Prescott and P.M. Dowling (Eds.) Antimicrobial Therapy in Veterinary Medicine. 5th Edition. Wiley Blackwell, USA, 79-103.
https://doi.org/10.1002/9781118675014.ch5
McBridge E.A., Magnus E., Hearne G. 2004. Behaviour problems in the domestic rabbit. In: D. Appleby (Ed.) The APBC book of companion animal behaviour. Souvenir Press, London, 167.
Park B.K., Lim J.H., Kim M.S., Hwang Y.H., Yun H.I. 2007. Pharmacokinetics of florfenicol and its major metabolite, florfenicol amine, in rabbits. J. Vet. Pharmacol. Ther., 30: 32-36. https://doi.org/10.1111/j.1365-2885.2007.00809.x
Sailer-Fleeger D. Appropriate Use of Antibiotics in Rabbits. House Rabbit Society. https://rabbit.org/health/antibiotics.html. Accessed April 2021.
Sarmento B., Ferreira D., Veiga F., Ribeiro A. 2006. Characterization of insulin-loaded alginate nanoparticles produced by ionotropic pre-gelation through DSC and FTIR studies. Carbohydr. Polym., 66: 1-7. https://doi.org/10.1016/j.carbpol.2006.02.008
Sun Z., Hao H., Xie C., Xu Z., Yin Q., Bao Y., Hou B., Wang Y. 2014. Thermodynamic Properties of Form A and Form B of Florfenicol. Ind. Eng. Chem. Res., 53: 13506-13512. https://doi.org/10.1021/ie5020525
The United States Pharmacopeial Convention. 2007. Florfenicol (Veterinary—Systemic). Available at: https://cdn.ymaws.com/www.aavpt.org/resource/resmgr/imported/florfenicol.pdf. Accessed August 2021.
Tønnesen H.H., Karlsen J. 2002. Alginate in drug delivery systems. Drug Dev. Ind. Pharm., 28: 621-630.
https://doi.org/10.1081/DDC-120003853
Toutain P.L., Sidu P.K., Lees P., Rassouli A., Pelligand L. 2019. VetCAST Method for Determination of the Pharmacokinetic-Pharmacodynamic Cut-Off Values of a Long-Acting Formulation of Florfenicol to Support Clinical Breakpoints for Florfenicol Antimicrobial Susceptibility Testing in Cattle. Front. Microbiol., 10: 1310. https://doi.org/10.3389/fmicb.2019.01310
Ueda Y., Suenaga I. 1995. In vitro antibacterial activity of florfenicol against Actinobacillus pleuropneumoniae. J. Vet. Med. Sci., 57: 363-364. https://doi.org/0.1292/jvms.57.363
Wang S., Chen N., Qu Y. 2011. Solubility of florfenicol in different solvents at temperatures from (278 to 318) K. J. Chem. Eng. Data, 56: 638-641. https://doi.org/10.1021/je1008284
Zhang W., Liu C., Chen S., Liu M., Zhang L., Lin S., Shu G., Yuan Z., Lin J., Peng G., Zhong Z., Yin L., Zhao L., Fu H. 2020. 2020. Poloxamer modified florfenicol instant microparticles for improved oral bioavailability. Colloids Surf. B Biointerfaces, 193: 1-8. https://doi.org/10.1016/j.colsurfb.2020.111078
Youssef F.S., El-Banna H.A., Elzorba H.Y., Galal A.M. 2019. Application of some nanoparticles in the field of veterinary medicine. Int. J. Vet. Sci. Med., 7: 78-93. https://doi.org/10.1080/23144599.2019.1691379
[-]